Dhunseri Tea & Industries Limited
DTIL · NSE · Consumer Defensive
StocksWizard rates Dhunseri Tea & Industries Limited a Sell, scoring 36/100 on our blended model. At ₹139.39 it trades below our blended DCF and relative-multiples fair value of ₹278.78, implying roughly 100% upside to that estimate — we read the stock as undervalued by 100%. Financial health scores 26/100 (grade F). It clears 4 of 10 investability checks, with durability 16, valuation 48 and momentum 46 on our 0–100 scales.
These are StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹223.02. Low-confidence estimate — limited data.
Investability checklist
- ✕ROE above 15%-0.5%
- ✓Low debt (D/E < 0.5)0.48x
- ✕Positive free cash flow
- ✕Revenue growth > 10%-36%
- –Earnings growing
- ✕Net margin ≥ 10%-0.5%
- ✕Current ratio > 1.50.70
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✕Above 200-day average
- ✓Above 50-day average
- –Positive 1-year return
- –Altman Z in safe zone
- –Piotroski ≥ 7
1-year price
EOD · 2026-06-19Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Shareholding
Promoter holding via insider stake; institutional via reported holdings.
Analyst views
Key fundamentals
SWOT snapshot
Weaknesses
- •Low return on equity (-0.5%).
- •Price below its 200-day moving average (downtrend).
Opportunities
- •Trades ~100% below our estimated fair value.
About Dhunseri Tea & Industries Limited
Dhunseri Tea & Industries Limited engages in the cultivation, manufacture, and sale of loose and packet tea in India and Internationally. The company produces and sells macadamia nuts. It also provides business management and consultancy
More in Consumer Defensive
All stocksOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.